HU
HUMAW
Humacyte, Inc.
$0.1100
0.00%
$4.5M
No data for this timeframe.
Vol
Market Cap$4.5M
Cap SizeNano Cap
Inst. Holders3 funds
Inst. Value$9.4K
Inst. Activity0 buys / 1 sells
SEC Reports2
Exchange Nasdaq·Sector Biological Products, (No Diagnostic Substances)·Inc. DE·CIK 0001818382·Prev Close $0.1100
Recent Activity
Jun 10, 2026
SEC
Humacyte reported positive interim results from its V012 Phase 3 study of the ATEV in female dialysis access patients, d
8-K — Impact 7/10
Apr 24, 2026
SEC
Humacyte has reacquired global commercial rights to its Symvess product from Fresenius, regaining full control over deve
8-K — Impact 7/10
Inst.
WOLVERINE ASSET MANAGEMENT LLC — TRIM
36,860 shares ($3.5K)
Inst.
WOLVERINE ASSET MANAGEMENT LLC — ADD
50,011 shares ($13.3K)
Latest Reports
BULLISH
8-K
7/10
Humacyte reported positive interim results from its V012 Phase 3 study of the ATEV in female dialysis access patients, d
Jun 10, 2026
BULLISH
8-K
7/10
Humacyte has reacquired global commercial rights to its Symvess product from Fresenius, regaining full control over deve
Apr 24, 2026
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $4.1K | — |
| WOLVERINE ASSET MANAGEMENT LLC | $3.5K | TRIM |
| TORONTO DOMINION BANK | $1.9K | — |
3 institutional holders with $9.4K total value (102,910 shares) as of 2026-Q1. Top holders: SUSQUEHANNA, WOLVERINE, TORONTO.
Top Institutional Holders — 2026-Q1
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 44,517 | $4.1K | 43.3% | — |
| 2 | WOLVERINE ASSET MANAGEMENT LLC | 37,975 | $3.5K | 36.9% | TRIM -26.3% |
| 3 | TORONTO DOMINION BANK | 20,418 | $1.9K | 19.8% | — |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| WOLVERINE ASSET MANAGEMENT LLC | TRIM | 50,011 | 36,860 | -26.3% | $3.5K | 2025-Q4 |
| WOLVERINE ASSET MANAGEMENT LLC | ADD | 31,849 | 50,011 | +57.0% | $13.3K | 2025-Q3 |
| WOLVERINE ASSET MANAGEMENT LLC | TRIM | 60,416 | 32,035 | -47.0% | $58.3K | 2024-Q4 |
No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.
2 SEC filing reports analyzed. Sentiment: 2 bullish, 0 bearish, 0 mixed, 0 neutral. Avg impact: 7.0/10.
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2026-06-30 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.0B | 269.7% | — |
| Next Q 2026-09-30 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.0B | 189.0% | — |
| Current FY 2026-12-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.0B | 218.8% | — |
| Next FY 2027-12-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.0B | 308.7% | — |
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
No events recorded for this ticker. Events include FDA actions, clinical trials, enforcement actions, and market-moving developments.